Produced image of a clinical and testing discussion · not actual Maru staff or a concluded partnership
FOR DOMESTIC & INTERNATIONAL PARTNERS
What partners need to know: Maru’s proposal.
Centered on veterinary care for companion animals, we present a partnership model that connects treatment systems, specialized testing, training and operational support. For hospitals in Korea we explain clinical and testing collaboration; for overseas buyers, an adoption structure operated together with local hospitals.
This is the partnership model presented in our business plan.
The following describes the scope proposed in the plan. The products actually available, responsible organizations, usage rights, prices, local permits and contracts are confirmed in adoption discussions. This does not mean that the plan’s descriptions of treatment effects have been independently verified.
Treatment systems
Chamber and related technology
The plan proposes placing life-energy and quantum-related treatment systems and the chamber in hospitals. Models, installation requirements, scope of application, safety data and maintenance are confirmed before adoption.
Testing services
Collection · Analysis · Report
We introduce the PetAge360 telomere test and the oral microbiome and cancer gene fields. Target animals, test items, sample requirements, reports and turnaround times are confirmed separately for each product.
Training and operations
Preparing to connect with clinical care
A training model covering equipment explanation, reading test results, the application process and progress records. Training scope, instructors, materials provided and follow-up support are discussed together.
Source: Korean business plan, p. 3 and pp. 12–16. Test names and functions are finally confirmed against the supplier’s current veterinary product materials.
DOMESTIC PARTNER CHECKLIST
For domestic partners, clarity on the work each will actually do.
How partner hospitals get started
Discuss the areas needed first among referrals, testing collaboration, equipment adoption and training
Confirm the attending veterinarian, place of care, target animals and intake criteria
Agree on what runs alongside existing care, and on owner explanation, consent and follow-up care
Check the process from intake to returning results through small-scale operation
Checklist for supply and operations partners
Contracting parties and supply authority; equipment ownership and rental terms
Supply of kits and consumables; equipment installation, inspection and breakdown response
Testing, procedure, training and logistics fees, and settlement responsibility
Handover in case of re-collection, refunds, delays, staff absence or contract termination
The success of a partnership is measured not by the number of hospitals but by whether actual clinical connections, completed tests, explanations of results and follow-up care continue. Operational checks do not replace verification of treatment effects.
Source: Comprehensive document, Implementation sections 6, 8, 9 and 10. This is a practical summary for domestic partnerships, not confirmed contract terms.
INTERNATIONAL BUYER / OPERATING MODEL
For overseas buyers: what to adopt, and how.
1. Two pillars of adoption
The plan proposes placement of treatment systems at local hospitals, and sample collection, analysis in Korea and report return, as two separate tracks. Starting with testing services can also be considered; the scope and schedule of equipment adoption and testing operations are discussed separately.
2. Roles in Korea and locally
Party
Role proposed in the plan
Points to agree in practice
Maru / Korean supply and analysis side
Treatment systems and related consumables, analysis in Korea, technical and report training
Supplier, analysis lab and trainer; documents provided; quality and support responsibilities
K-Link
Finding local partners, regional negotiations and business coordination
Actual participation in contracts, agency authority, roles and point of contact
Local branch / buyer
Hospital network, local adoption procedures, supply, sales, settlement and after-sales support
Territory, legal entity, facilities, operational capacity and cost sharing
Local animal hospitals and veterinarians
Treating patients, collecting samples, explaining results and managing follow-up
Local practice licensing, medical responsibility and owner consent
3. Linking samples and results
Collected at local hospitals
Samples are collected according to each product’s guidelines and linked to the animal’s information and an intake number.
Transported to the analysis lab in Korea
Whether export and import are permitted, as well as storage, packaging, shipping and sample acceptance criteria, are confirmed first.
Analysis and report
The actual lab, test method, criteria and limitations, and expected result date are confirmed.
Results returned locally
Explanations in the local language are linked with the attending veterinarian’s interpretation and follow-up care.
4. Training and technical support
The plan proposes that local veterinarians receive training in Korea in theory, equipment, hands-on practice and report reading, and then apply it in local operations. Listed training topics include telomere-related protocols, microcirculation, light fusion and gold thread, and PetAge360 report reading. The courses actually available, qualifications and usage rights, interpreting, duration, costs and after-sales support are agreed separately.
5. Adoption costs and regional rights
The plan’s cost and revenue structure consists of equipment supply or rental, per-test fees, consumables, and training and support. Amounts, revenue-sharing ratios and minimum operating volumes are not presented as fixed figures. Retesting intervals are likewise set according to product evidence and the veterinarian’s judgment, and recurring revenue is not guaranteed.
Regional branches and conditional exclusivity and recruitment rights are proposals in the plan. Whether rights cover a whole country or a specific region, as well as their term, products, performance conditions, renewal, termination and resale rights, are confirmed in the contract. Because the plan mentions sale, rental and free rental as equipment supply methods, final ownership, custody and return terms must be negotiated.
Source: Korean business plan, p. 12 (products and adoption), p. 13 (sample cycle), pp. 14–15 (organizations, regional rights and training), p. 18 (cost and revenue structure). The above does not confirm any local permit or supply contract.
FROM REVIEW TO PILOT
From document review to a local pilot.
Confirm the buyer’s region and capabilities
Summarize the country, responsible entity, affiliated hospitals and veterinarians, products of interest and expected operating scale.
Review adoption materials
Review equipment specifications, safety and performance data, rights documents, veterinary test descriptions, anonymized reports, original case records and training scope. Patents are distinguished from certification of treatment effects.
Agree on supply and local conditions
Finalize quotes, logistics, permits, sample export and import, data handling, language, settlement and support responsibilities. We do not give blanket statements that permits are unnecessary in a particular country.
Small-scale pilot operation
Check the turnaround time for collection → intake → analysis → return, and the procedures for training, explanation and equipment support.
Expand after reviewing results
Review actual operating records and agree on contract scope, follow-up care and the next supply.
Information needed for the first discussion
Country, city, company or hospital name, and contact person
Hospital network and whether local veterinarians will take part
Areas of interest among testing, equipment and training, and planned scale
Preferred schedule, document language, local logistics and adoption experience
Questions about regional rights, costs, training and support
Source: Korean business plan, pp. 19–21, and Comprehensive document, Implementation sections 5, 9 and 10. The quarterly schedule in the plan is a planned outline, not a confirmed delivery date or service launch date.
DOMESTIC HOSPITAL PARTNERS
Starting with hospitals in Korea: clinical and testing partnerships.
We discuss together how to connect Maru’s core treatments and specialized testing partnerships to the clinical workflow of other animal hospitals. We distinguish treatment referrals from testing collaboration, and aim for a structure in which roles between hospitals and explanations to owners connect smoothly.
A partnership starts not by increasing the number of hospitals but by defining the work each will actually take on. After agreeing specifically on target animals, areas to be provided, referral and feedback methods and follow-up care, we review the process on a small scale.
Clinical partnership
Referral and feedback
We share the animal’s condition and the purpose of the referral, and pass the clinical details and next plan on to the responsible hospital.
Testing
Collection and analysis
We align sample and analysis criteria for each product, the delivery of results and the veterinarian’s explanation.
Training partnership
Explanation and records
We share materials for understanding test interpretation and real cases, operational explanations and methods for recording progress.
AREAS TO DISCUSS
Three partnership areas to discuss together.
01
Core treatment collaboration
We discuss explanations of telomere, chamber and quantum-related treatment approaches and clinical referrals for individual animals. The actual scope of application and responsibilities are set specifically by the veterinarian and the party responsible for the technology or equipment.
We aim to connect telomere, oral microbiome, cancer gene and hereditary disease test information with the hospital’s consultations. Target animals and supply and analysis conditions for each product are set in actual discussions.
We discuss training and resource sharing covering the scope of interpreting test results, how to read cases, and referral, result delivery and progress records.
Initial examination and explanation, referral information and sample preparation, contact with owners
Target animals, purpose of referral, attending veterinarian, follow-up care
Maru clinical team
Reviewing referrals, explaining the scope of care provided, returning clinical details and plans
Intake criteria, place and schedule of care, feedback method
Testing lab / supplier
Kit guidelines, sample suitability, analysis, reports and test inquiries
Analysis items, shipping, turnaround and re-collection conditions
Coordination contact
Communication between organizations, status checks and agreed operating records
Point of contact, handover, and response to delays or interruptions
These are role divisions to be agreed in partnership design. Each organization’s actual responsibilities and contract terms are set through the relevant discussions.
CLINICAL REFERRAL & FEEDBACK
From referral to feedback, we connect clinical information.
What to share when referring
The animal’s basic information and current symptoms
Previous tests, imaging and clinical records, and current medications
Purpose of the referral and the attending veterinarian’s questions
What has been explained to the owner and the scope of consent
What to carry forward in the feedback
Findings from the examination and treatments applied
Items to watch in concurrent care and follow-up observation
Follow-up care plan and each hospital’s responsibilities
Next contact and how to check the animal’s condition
We define what the referring hospital and the treating hospital each need to know. This is not a process that leads automatically to a specific treatment; a veterinarian reviews whether it applies to each animal.
TESTING WORKFLOW
Until each test is complete, we align every step together.
Explain the purpose and target of the test.
The hospital and testing staff agree on test items, limitations, preparation and the scope of cost explanations.
Collect and ship according to each product’s guidelines.
Samples are accurately matched with referral information, and storage, shipping and intake requirements are followed.
Confirm intake and results with the analysis lab.
Sample suitability, expected result timing and the procedure if re-collection is needed are shared among the staff involved.
Explain the report together with clinical information.
The lab’s explanation of the analysis and the veterinarian’s clinical judgment are kept distinct when explaining to the owner.
Continue observation and handle inquiries.
Determine whether the owner understood the results, whether further consultation or care is needed, and who will handle follow-up questions.
Costs and operating terms are agreed as well.
We discuss the supply, analysis and explanation scope for each product, cost sharing, re-collection, cancellation and refunds, and who is responsible for contact if results are delayed. This page does not present any unconfirmed terms of use.
TRAINING & SHARED MATERIAL
Sharing resources, aligning how we explain.
Understanding tests
Purpose · Measurement · Interpretation
Covers what each test measures, report structure, the scope of interpretation and owners’ questions.
Understanding cases
Types of records
We share how to explain cases by distinguishing hospital explanations, photos, tests and clinical records.
Understanding operations
Step-by-step practice
We align on referral, collection, intake, result delivery, progress records and handover between organizations.
Training on technologies or equipment follows the scope permitted by the rights holders and responsible experts. Sharing materials or taking part in training is not described as automatically granting usage rights or qualifications for any specific technology.
PARTNERSHIP STEP BY STEP
Partnership, one concrete step at a time.
Tell us your hospital’s needs and areas of interest.
We narrow down which work is needed first: referrals, testing collaboration or training.
Align on scope and responsibilities.
We confirm the actual staff, the scope of care, analysis and supply, and schedules, contacts and terms.
Review the process on a small scale.
We check that everything connects from intake to results and feedback, and that the work and owner explanations run without difficulty.
Review records and improve the process.
We sort out issues with delays, re-collection, inquiries and handover, and apply the lessons to the next round.
Expand the partnership within the confirmed scope.
Expansion is discussed based on whether the actual work and responsibility structure hold up.
Small-scale operational checks and clinical research to verify treatment effects have separate purposes and procedures.
INTERNATIONAL PARTNER DIRECTION
Connections built in Korea, together with local hospitals.
Our international partnerships are directed toward a partner structure centered on local animal hospitals and veterinarians. Going beyond translating our Korean materials, we define roles to fit local clinical, analysis, supply and explanation processes.
What we prepare on the Korean side
We organize clinical, testing and case materials that can be disclosed, roles by organization, training and operational explanations, and the agreed scope of supply and contact.
What to align with local partners
We discuss target animals and products, local clinical responsibility, language and result explanation, sample handling and supply methods, and follow-up care and inquiry handling.
Clinical, testing, shipping, product and data-handling requirements in each country must be confirmed according to the actual targets and methods. We do not present contracts, exclusive rights or local services in any specific country as already confirmed.
PREPARE FOR A CONVERSATION
Preparing before we talk makes the discussion more concrete.
Hospital name, region, attending veterinarian and business contact
Areas of interest: referrals, testing, training, international partnership
Work you want to connect with your current clinical workflow
Target animals and expected operating scope
Staff responsible for samples, reports and owner explanations
Questions to confirm first on schedule, supply, costs and responsibilities
General partnership discussions do not require sharing individual medical records in bulk. At the actual referral stage, the necessary information and scope of consent are defined before anything is shared.
QUESTIONS & ANSWERS
Common questions when discussing a partnership.
Can we discuss only the testing partnership first?+
Discussions can start with the specific area you are interested in. Testing collaboration and clinical and treatment partnerships each have their own scope and responsibilities.
Can we use the equipment right after training?+
Training is separate from equipment supply and usage rights. The actual application of equipment, responsibilities and required conditions must be set separately by the responsible experts and rights holders.
What is confirmed first in a partnership between hospitals?+
We first confirm the purpose of the referral, the scope of testing, result delivery and owner explanations. Costs and cancellation and refund terms require agreement between the organizations before actual work begins.
Are nationwide branches or overseas exclusive rights included?+
Business cooperation between hospitals is separate from regional, exclusive or supply rights. The scope, term, subject and responsibilities of any rights must be agreed separately.
Do we need to handle many cases from the start?+
The approach is to first agree on scope and responsibilities, then confirm on a small scale that intake, analysis, feedback and explanation connect smoothly.